How Will the Market React to ReShape Lifesciences Inc (RSLS) Stock Getting a Bearish Rating

Overall market sentiment has been down on ReShape Lifesciences Inc (RSLS) stock lately. RSLS receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

ReShape Lifesciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on RSLS!

See Full RSLS Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With RSLS Stock Today?

ReShape Lifesciences Inc (RSLS) stock is trading at $1.26 as of 10:55 AM on Wednesday, Aug 9, a drop of -$0.02, or -1.56% from the previous closing price of $1.28. The stock has traded between $1.26 and $1.30 so far today. Volume today is light. So far 12,851 shares have traded compared to average volume of 125,789 shares. To see InvestorsObserver's Sentiment Score for ReShape Lifesciences Inc click here.

More About ReShape Lifesciences Inc

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. Click Here to get the full Stock Report for ReShape Lifesciences Inc stock.